The “Therapeutic Antibodies and Immunoblotting” team is delighted to announce that it has recently been awarded two significant grants, testifying to the recognition of its work by renowned institutions. These research projects, coordinated by Rémi Lasserre, aim to deepen our understanding of immune mechanisms and develop cutting-edge cellular therapies.

ANR : Collaborative Research Project (CRP) 2024
TCELL-CODE Deciphering the T cell response to TCR stimulation dynamics

THE LEAGUE AGAINST CANCER 2024: “Innovative cellular therapies
CARMA project: Tailoring CAR T Cell Metabolism and Activation to Enhance Therapeutic Efficacy

Thanks to this funding, the team will continue its efforts to develop innovative therapies and help improve treatment prospects for patients.